文献速递心脑血管急症重症综合管理与镇静镇痛

不同治疗方案中心的 optimal cerebral perfusion pressure 差异

Optimal Cerebral Perfusion Pressure in Centers With Different Treatment Protocols.
PubMed 文献 · Crit Care Med · 2018-01-01
一句话结论三个创伤性脑损伤中心因年龄和脑灌注压目标不同,计算出的 optimal cerebral perfusion pressure 存在差异,设计自动调节导向治疗试验时应考虑这些因素。

本研究为回顾性分析前瞻性收集的数据,纳入英国剑桥、荷兰格罗宁根和瑞典乌普萨拉三个神经重症监护室的104例创伤性脑损伤患者(剑桥35例、格罗宁根35例、乌普萨拉34例)。各中心脑灌注压目标不同:格罗宁根≥50且<70 mm Hg,乌普萨拉≥60 mm Hg,剑桥≥60或优选≥70 mm Hg,但各中心中位脑灌注压均高于70 mm Hg。乌普萨拉脑灌注压与 optimal cerebral perfusion pressure 差值最大,且该中心患者年龄较大,年龄与差值正相关;格罗宁根 optimal cerebral perfusion pressure 显著低于剑桥;有效 optimal cerebral perfusion pressure 监测时间百分比无显著差异。结论认为 optimal cerebral perfusion pressure 计算差异由人口学(年龄)和治疗(脑灌注压目标)因素导致,设计自动调节导向治疗试验时应考虑。

要点

  • 三个中心脑灌注压目标不同:格罗宁根≥50且<70 mm Hg,乌普萨拉≥60 mm Hg,剑桥≥60或优选≥70 mm Hg,但各中心中位脑灌注压均高于70 mm Hg。
  • 乌普萨拉脑灌注压与 optimal cerebral perfusion pressure 差值最大,该中心患者年龄大于其他中心,年龄与差值正相关。
  • 格罗宁根 optimal cerebral perfusion pressure 显著低于剑桥。
  • 各中心有效 optimal cerebral perfusion pressure 监测时间百分比无显著差异。
  • 格罗宁根和剑桥可生成汇总 optimal cerebral perfusion pressure 曲线,乌普萨拉不能,乌普萨拉患者年龄较大可能解释该现象。

适用人群与场景

  • 纳入104例创伤性脑损伤患者:剑桥35例、格罗宁根35例、乌普萨拉34例,来自三个大学医院神经重症监护室。

处置流程与药物剂量

  • 格罗宁根脑灌注压目标为≥50且<70 mm Hg。
  • 乌普萨拉脑灌注压目标为≥60 mm Hg。
  • 剑桥脑灌注压目标为≥60 mm Hg或优选≥70 mm Hg。

研究设计与关键结果

  • 研究类型为回顾性分析前瞻性收集的数据,纳入104例创伤性脑损伤患者,来自英国剑桥、荷兰格罗宁根和瑞典乌普萨拉三个神经重症监护室。
  • 尽管方案不同,各中心中位脑灌注压均高于70 mm Hg。
  • 乌普萨拉脑灌注压与 optimal cerebral perfusion pressure 差值最大;乌普萨拉患者年龄大于其他中心,年龄与差值正相关。
  • 格罗宁根 optimal cerebral perfusion pressure 显著低于剑桥。
  • 各中心有效 optimal cerebral perfusion pressure 监测时间百分比无显著差异。
  • 格罗宁根和剑桥可生成汇总 optimal cerebral perfusion pressure 曲线,乌普萨拉不能;乌普萨拉患者年龄较大可能解释汇总曲线缺失。

证据类型、等级与局限

  • 证据类型:回顾性分析前瞻性收集的数据。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,optimal cerebral perfusion pressure 计算在不同中心间存在差异,由人口学(年龄)和治疗(脑灌注压目标)因素导致,设计自动调节导向治疗疗效试验时应考虑这些因素。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: The three centers in this study have different policies regarding cerebral perfusion pressure targets and use of vasopressors in traumatic brain injury patients. The aim was to determine if the different policies affected the estimation of cerebral perfusion pressure which optimizes the strength of cerebral autoregulation, termed "optimal cerebral perfusion pressure."

DESIGN: Retrospective analysis of prospectively collected data.

SETTING: Three neurocritical care units at university hospitals in Cambridge, United Kingdom, Groningen, the Netherlands, and Uppsala, Sweden.

PATIENTS: A total of 104 traumatic brain injury patients were included: 35 each from Cambridge and Groningen, and 34 from Uppsala.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: In Groningen, the cerebral perfusion pressure target was greater than or equal to 50 and less than 70 mm Hg, in Uppsala greater than or equal to 60, and in Cambridge greater than or equal to 60 or preferably greater than or equal to 70. Despite protocol differences, median cerebral perfusion pressure for each center was above 70 mm Hg. Optimal cerebral perfusion pressure was calculated as previously published and implemented in the Intensive Care Monitoring+ software by the Cambridge group, now replicated in the Odin software in Uppsala. Periods with cerebral perfusion pressure above and below optimal cerebral perfusion pressure were analyzed, as were absolute difference between cerebral perfusion pressure and optimal cerebral perfusion pressure and percentage of monitoring time with a valid optimal cerebral perfusion pressure. Uppsala had the highest cerebral perfusion pressure/optimal cerebral perfusion pressure difference. Uppsala patients were older than the other centers, and age is positively correlated with cerebral perfusion pressure/optimal cerebral perfusion pressure difference. Optimal cerebral perfusion pressure was significantly lower in Groningen than in Cambridge. There were no significant differences in percentage of monitoring time with valid optimal cerebral perfusion pressure. Summary optimal cerebral perfusion pressure curves were generated for the combined patient data for each center. These summary curves could be generated for Groningen and Cambridge, but not Uppsala. The older age of the Uppsala patient cohort may explain the absence of a summary curve.

CONCLUSIONS: Differences in optimal cerebral perfusion pressure calculation were found between centers due to demographics (age) and treatment (cerebral perfusion pressure targets). These factors should be considered in the design of trials to determine the efficacy of autoregulation-guided treatment.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Howells T, Smielewski P, Donnelly J, et al. Optimal Cerebral Perfusion Pressure in Centers With Different Treatment Protocols. Crit Care Med. 2018. PMID: 29293154. doi:10.1097/CCM.0000000000002930

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。